Search Results - "Peiffer, K."

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection by Vermehren, J., Peiffer, K.‐H., Welsch, C., Grammatikos, G., Welker, M.‐W., Weiler, N., Zeuzem, S., Welzel, T. M., Sarrazin, C.

“…Summary Background Direct antiviral therapies for chronic hepatitis C virus (HCV) infection have expanded treatment options for neglected patient populations,…”
Get full text

No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct‐acting antivirals for hepatitis C in a large real‐world cohort by Mücke, V. T., Mücke, M. M., Peiffer, K.‐H., Weiler, N., Welzel, T. M., Sarrazin, C., Zeuzem, S., Berger, A., Vermehren, J.

“…Summary Background Hepatitis B virus (HBV) reactivation has been observed following interferon (IFN)‐based treatment in HBV/hepatitis C virus (HCV) co‐infected…”
Get full text

Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection by Kuhnhenn, L., Jiang, B., Kubesch, A., Vermehren, J., Knop, V., Susser, S., Dietz, J., Carra, G., Finkelmeier, F., Grammatikos, G., Zeuzem, S., Sarrazin, C., Hildt, E., Peiffer, K.‐H.

“…Summary Background HBV DNA and quantitative (q)HBsAg levels as prognostic markers for HBV‐related disease are mostly validated in Asia and their significance…”
Get full text

Editorial: HBsAg serum levels in HBeAg‐negative chronic HBV infection—is it a matter of genotype? Authors’ reply by Kuhnhenn, L., Jiang, B., Kubesch, A., Zeuzem, S., Sarrazin, C., Hildt, E., Peiffer, K.‐H.

“…Linked Content This article is linked to Kuhnhenn et al and Alexopoulou and Karayiannis papers. To view these articles visit https://doi.org/10.1111/apt.14636…”
Get full text

Hepatitis B Virus Precore-, Basal Core Promotor- and Pres-Gene Variants: Importance for Reactivation in a Large Cohort of HBS Antigen Carriers by Sommer, L, Peiffer, K.-H, Vermehren, J, Knop, V, Sarrazin, C, Zeuzem, S

Get full text

Correlation of hepatitis B virus genomic variants with HBsAg Titers and HBV-DNA levels in a large European study cohort of patients with chronic hepatitis B by Peiffer, K.-H, Sommer, L, Susser, S, Dietz, J, Vermehren, J, Knop, V, Zeuzem, S, Hildt, E, Sarrazin, C

Get full text

High sustained virologic response rates in hepatitis C virus genotype 3 patients with and without cirrhosis treated with daclatasvir/sofosbuvir or velpatasvir/sofosbuvir ± ribavirin according to baseline resistance analysis by Vermehren, J, Dietz, J, Peiffer, K.-H, Weiler, N, Mücke, V, Dultz, G, Welsch, C, Zeuzem, S, Welzel, T.M, Sarrazin, C

Get full text

P0728 : Investigation of genetic recombination of hepatitis C virus in patients infected with genotypes 1, 2 and 4 by Dietz, J, Hamdi, N, Peiffer, K.-H, Susser, S, Berkowski, C, Perner, D, Zeuzem, S, Sarrazin, C

Get full text

Direct Antiviral Combination Treatment According to Presence of Baseline Ravs in NS3, NS5A and NS5B Leads to High SVR Rates in Non-Cirrhotic and Cirrhotic Genotype 1 Infected Patients by Peiffer, K.-H, Susser, S, Dietz, J, Berkowski, C, Perner, D, Passmann, S, Raeder, M, Vermehren, J, Lange, C, Klein, S, Weiler, N, Zeuzem, S, Sarrazin, C

Get full text

Resistance patterns in patients with chronic hepatitis C genotype 4 infection and treatment outcome by Dietz, J, Vermehren, J, Susser, S, Peiffer, K.-H, Grammatikos, G, Perner, D, Müllhaupt, B, Buggisch, P, Petersen, J, Schattenberg, J, Galle, P, Chave, J.-P, Kuhn, M, Zachoval, R, Niederau, C, Schulze zur Wiesch, J, Moreno, C, Berg, T, Berg, C, Zeuzem, S, Sarrazin, C

Get full text

European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients by Susser, S, Dietz, J, Vermehren, J, Peiffer, K.-H, Passmann, S, Perner, D, Berkowski, C, Ferenci, P, Buti, M, Müllhaupt, B, Hunyadi, B, Hinrichsen, H, Mauss, S, Petersen, J, Buggisch, P, Schober, A, Felten, G, Hüppe, D, Zipf, A, Knecht, G, Lutz, T, Berg, T, Zeuzem, S, Sarrazin, C

Get full text

506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS by Vermehren, J, Aghemo, A, Peiffer, K.-H, Susser, S, D'Ambrosio, R, Perner, D, Gerber, L, Soffredini, R, Weiland, O, Zeuzem, S, Colombo, M, Sarrazin, C

Get full text

819 IMPROVED PHARMACODYNAMICS AND PHARMACOKINETICS AFTER INTRAVENOUS APPLICATION OF PEG-INTERFERON alfa-2a 180 μg IN CHRONIC HEPATITIS C GENOTYPE 1 NULLRESPONDERS TO PEGINTERFERON/RIBAVIRIN. THE IVAN STUDY by Fueloep, B, Biermer, M, Heyne, R, Wedemeyer, H, Cornberg, M, Port, K, Zeuzem, S, Peiffer, K.-H, Koenig, S, Herber, A, Boehlig, A, Wiegand, J, Buggisch, P, Stoll, S, Alshuth, U, Berg, T

Get full text

Evidence for expression of siRNA directed against RUNX2 mRNA by psilencer in mesenchymal progenitor cells by Peiffer, K, Tzvetkov, M, Miosge, N, Köpp, R, Blaschke, M, Siggelkow, H

Get full text

On Passive Stabilization in Critical Cases by Peiffer, K., Savchenko, A.Ya

“…The attitude of a satellite is often controlled by reactive forces requiring some additional energy. But it can also be stabilized by means of some subsystem…”
Get full text

Clinical and virological characteristics of DAA-experienced patients with chronic HCV infection treated with sofosbuvir/ velpatasvir/voxilaprevir: results from the Frankfurt Resistance Database by Vermehren, J., Dietz, J., Peiffer, K.-H., Susser, S., Zeuzem, S., Sarrazin, C.

Get full text

THU-347 - Clinical and virological characteristics of DAA-experienced patients with chronic HCV infection treated with sofosbuvir/ velpatasvir/voxilaprevir: results from the Frankfurt Resistance Database by Vermehren, J., Dietz, J., Peiffer, K.-H., Susser, S., Zeuzem, S., Sarrazin, C.

Get full text

Editorial: HB sAg serum levels in HB eAg‐negative chronic HBV infection—is it a matter of genotype? Authors’ reply by Kuhnhenn, L., Jiang, B., Kubesch, A., Zeuzem, S., Sarrazin, C., Hildt, E., Peiffer, K.‐H.

“…Linked Content This article is linked to Kuhnhenn et al and Alexopoulou and Karayiannis papers. To view these articles visit https://doi.org/10.1111/apt.14636…”
Get full text

SAT-372 - HBsAg transcomplementation of defective HBV genomes in HBeAg negative chronic HBV infected patients by Peiffer, K.-H., Kuhnhenn, L., Jiang, B., Vermehren, J., Knop, V., Zeuzem, S., Sarrazin, C., Hildt, E.

Get full text

HBsAg transcomplementation of defective HBV genomes in HBeAg negative chronic HBV infected patients by Peiffer, K.-H., Kuhnhenn, L., Jiang, B., Vermehren, J., Knop, V., Zeuzem, S., Sarrazin, C., Hildt, E.

Get full text